VAERS reports by lot

Pfizer COVID-19 lot NA0589: VAERS reports

84 VAERS reports list lot NA0589 as a Pfizer COVID-19 vaccine, received between 2025-09-10 and 2026-04-20. Data: VAERS public files through 28 May 2026 (site extract 2026-10-28).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
84
Reports
2%
Marked serious
0
With a death outcome
7
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction5221%
Neurological4819%
General / Systemic (non-local)3715%
Dermatological (non-injection-site)2811%
Musculoskeletal2510%
Cardiac / Cardiovascular187%
Gastrointestinal177%
Allergic / Anaphylactic114%
Respiratory62%
Thrombotic / Hematological42%
Psychiatric / Neuropsychiatric21%

Where reports came from

U.S. state of the reporter, where given (top 12).

StateReports
California12
Florida10
North Carolina6
New Mexico5
South Carolina5
Pennsylvania4
Colorado4
Texas4
Tennessee3
Minnesota3
Ohio2
Alabama2

Reports by month received

MonthReportsBar
2025-0913
2025-1041
2025-1116
2025-127
2026-014
2026-021
2026-042

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Nearby Pfizer COVID-19 lots (A–Z): MY9548 · MY9550 · NA0587 · NA0590 · NA0738 · NA0739

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-10-28 18:08 UTC. Not medical advice. Report errors via contact.